Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Maintains Outperform on Uber Technologies, Raises Price Target to $40

Wedbush Maintains Outperform on Uber Technologies, Raises Price Target to $40

Wedbush analyst Daniel Ives maintains Uber Technologies (NYSE:UBER) with a Outperform and raises the price target from $38 to $40.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Wedbush analyst Daniel Ives maintains Uber Technologies (NYSE:UBER) with a Outperform and raises the price target from $38 to $40.

Analyst Ratings

Where Armstrong World Stands With Analysts

By Benzinga Insights

August 18, 8:13 AM

Analysts have provided the following ratings for Armstrong World Indus (NYSE:AWI) within the last quarter:

AWI

These Analysts Boost Their Forecasts On Sage Therapeutics Following Q4 Results

By Avi Kapoor

February 15, 1:59 PM

Sage Therapeutics, Inc. (NASDAQ: SAGE) reported better-than-expected fourth-quarter revenue results on Wednesday.

SAGE

News

‘Tesla Full Self-Driving Price Officially Increased To $15,000’ – Insideevs

By Benzinga Newsdesk

September 6, 8:26 AM

https://insideevs.com/news/608626/tesla-fsd-price-increased-15000-dollars/?adv=0

TSLA

CorMedix Inc. Announces Issuance Of U.S. Patent Covering Lead Product Defencath

By Happy Mohamed

August 30, 8:04 AM

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that

CRMD

Wedbush Maintains Outperform on Uber Technologies, Raises Price Target to $40

Related Posts

Where Armstrong World Stands With Analysts

These Analysts Boost Their Forecasts On Sage Therapeutics Following Q4 Results

‘Tesla Full Self-Driving Price Officially Increased To $15,000’ – Insideevs

CorMedix Inc. Announces Issuance Of U.S. Patent Covering Lead Product Defencath